Skip to content

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Theranostics Online Congresses - Join Medical Events.

Clinical Studies

ITM's Clinical Trials for GEP-NET Patients

Two phase 3 clinical trials are undergoing to evaluate targeted radionuclide therapy with n.c.a. lutetium-177-edotreotide in patients with neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NETs).

COMPETE - Treatment Schedule

COMPOSE - Treatment Schedule

For more information, please check out www.itm-gep-net-trials.com